Narashino, Japan

Shunichi Murata

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shunichi Murata: Innovator in Pharmaceutical Science

Introduction

Shunichi Murata is a notable inventor based in Narashino, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments. With a total of 3 patents to his name, Murata's work has the potential to impact patient care positively.

Latest Patents

One of Murata's latest patents involves a polymorphic form of sepiapterin. This patent discloses a crystalline form of sepiapterin, along with a method for preparing this crystalline form. It also includes pharmaceutical compositions containing the crystalline form and a method for treating patients with diseases associated with low intracellular BH4 levels or dysfunction in various BH4-dependent metabolic pathways. The treatment involves administering an effective amount of the crystalline form to the patient.

Career Highlights

Throughout his career, Shunichi Murata has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with PTC Therapeutics, Inc. and Shiratori Pharmaceutical Co., Ltd. His work in these organizations has allowed him to contribute to advancements in drug development and patient treatment options.

Collaborations

Murata has collaborated with several professionals in his field, including Hiroshi Yoshino and Taichi Komoda. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical science.

Conclusion

Shunichi Murata's contributions to the field of pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…